Invitation to offer for NHS National Pharmaceuticals — Wave 10c

Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months.

Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28.2.2019 (20 months) Hospital Only Products: Central and South West (CESW) 1.7.2017 to 30.6.2018 (12 months); North West and Eastern and North London (NWLN) 1.7.2017 to 30.6.2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 1.7.2017 to 30.6.2018 (12 months).

NHS National Pharmaceuticals — Wave 10c.

Offer reference number: CM/PHG/15/5466.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months.

Potential periods of call-offs under the framework agreement: Oral Products: All Regions 1.7.2017 to 28.2.2019 (20 months).

NHS National Pharmaceuticals — Wave 10c.

Offer reference number: CM/PHG/15/5466.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 24 months.

Potential periods of call-offs under the framework agreement: Hospital Only Products: Central and South West (CESW) 1.7.2017 to 30.6.2018 (12 months).

NHS National Pharmaceuticals — Wave 10c.

Offer reference number: CM/PHG/15/5466.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 24 months.

Potential periods of call-offs under the framework agreement: Hospital Only Products: South East and South London and North East and Yorkshire (LSNE) 1.7.2017 to 30/06/2018 (12 months).

NHS National Pharmaceuticals — Wave 10c.

Offer reference number: CM/PHG/15/5466.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 24 months.

Potential periods of call-offs under the framework agreement: Hospital Only Products: North West and Eastern and North London (NWLN) 1.7.2017 to 30.6.2018 (12 months).